5. ⢠Bacteriostatic at low but cidal (for certain
bacteria only) at high concentrations
⢠Gram-positive bacteria accumulate
erythromycin intracellularly by active
transport
⢠Activity is enhanced in alkaline medium
⢠Acts by inhibiting bacterial protein synthesis
⢠Combines with 50S ribosome subunits and
interferes with âtranslocation
6. Contd.
⢠Peptide bond formation between the newly
attached amino acid and the nacent peptide
chain at the acceptor (A) site
⢠The elongated peptide is translocated back to
the peptidyl (P) site
⢠Prevented by erythromycin
8. A. As an alternative to penicillin
⢠Streptococcal pharyngitis, tonsillitis,
mastoiditis
⢠Community acquired respiratory infections
caused by pneumococci and H. influenzae
⢠Prophylaxis rheumatic fever and SABE
⢠Diphtheria:
â 7 day treatment is recommended
⢠Tetanus:
10. B. As a first choice drug for
⢠Atypical pneumonia caused by Mycoplasma
pneumoniae
⢠Whooping cough
â 1â2 week course is the most effective treatment
for eradicating B. pertussis from upper respiratory
tract
⢠Chancroid: 150 mg 12 hrly for 7 days
11. As a second choice drug in
⢠Campylobacter enteritis
⢠Legionnairesâ pneumonia
⢠Chlamydia trachomatis
⢠Penicillin-resistant Staphylococcal infections
â not effective against MRSA
12. ďąRoxithromycin
⢠Similar to erythromycin except
⢠More preferred for otitis media,sinusitis and
pneumonia caused by moraxella catarhalis
and legionella
17. Advantages
⢠Expanded spectrum
⢠Improved pharmacokinetics
⢠better tolerability
⢠Less drug interactions
⢠Convent once daily dosing schedule
18. PK features
⢠acid-stability
⢠rapid oral absorption
⢠larger tissue distribution and intracellular
penetration
⢠Particularly high concentrations are attained
inside macrophages and fibroblasts
19. USES
⢠Legionnairesâ pneumonia: 500 mg OD oral/
i.v. for 2 weeks.
⢠Chlamydia trachomatis:1 g single dose
⢠Lymphogranuloma venerum
⢠Chlamydial pneumonia: drug of choice
⢠Donovanosis caused by Calymmatobacterium
granulomatis
⢠Chancroid and PPNG urethritis:1 g single dose
20. Other uses
⢠Pharyngitis, tonsillitis, sinusitis, otitis media
⢠Pneumonias, acute exacerbations of chronic
bronchitis
⢠streptococcal and some staphylococcal skin
and soft tissue infections
⢠prophylaxis and treatment of MAC in AIDS
patient
23. ⢠Drug of choice for treatment of infections
caused by MRSA is:
⢠(a) Metronidazole
⢠(b) Vancomycin
⢠(c) Imipenem
⢠(d) Clindamycin
24. ⢠The antibiotic causing pseudomembrane
colitis is:
⢠(a) Clindamycin
⢠(b) Garamycin
⢠(c) Erythromycin
⢠(d) Vancomycin
25. ⢠Antibiotic which is effective as a single dose
therapy
⢠for trachoma is:
⢠(a) Doxycycline
⢠(b) Clarithromycin
⢠(c) Azithromycin
⢠(d) Erythromycin
26. ⢠Drug of choice for Treponema pallidum is:
⢠(a) Penicillin G
⢠(b) Tetracycline
⢠(c) Azithromycin
⢠(d) Doxycycline
27. ⢠Which of the following antibacterial causes
both ototoxicity and nephrotoxicity:
⢠(a) Methicillin
⢠(b) Vancomycin
⢠(c) Clindamycin
⢠(d) Azithromycin
28. ⢠All of the following are common
antimicrobial agents used in treatment of
typhoid fever except:
⢠(a) Ceftriaxone
⢠(b) Quinolones
⢠(c) Clindamycin
⢠(d) Azithromycin
29. ⢠The drug of choice in lymphogranuloma
venereum is:
⢠(a) Penicillin
⢠(b) Ciprofloxacin
⢠(c) Tetracycline
⢠(d) Erythromycin
30. ⢠Drug inhibiting bacterial protein synthesis are
all
⢠except:
⢠(a) Aminoglycosides
⢠(b) Chloramphenicol
⢠(c) Clindamycin
⢠(d) Sulfonamides
36. ⢠Which of the following is not nephrotoxic?
⢠(a) Tobramycin
⢠(b) Kanamycin
⢠(c) Ampicillin
⢠(d) Amphotericin B
37. ⢠A diabetic patient develops cellulitis due to
Staphylococcus aureus that was found to be
methicillin resistant on the antibiotic
sensitivity testing. All of the following
antibiotics will be appropriate EXCEPT:
⢠(a) Vancomycin
⢠(b) Imipenem
⢠(c) Teicoplanin
⢠(d) Linezolid